Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

v3.22.1
Stockholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of warrant activity
    Number
of
    Weighted
Average
Exercise
    Weighted
Average
Remaining
Contractual
    Aggregate
Intrinsic
 
Warrants   Shares     Price     Term     Value  
Balance Outstanding, December 31, 2021     9,258,191     $ 0.45       6.85     $ 304,799  
Granted    
-
     
-
     
-
     
-
 
Forfeited    
-
     
-
     
-
     
-
 
Exercised    
-
     
-
     
-
     
-
 
Expired    
-
     
-
     
-
     
-
 
Balance Outstanding, March 31, 2022     9,258,191     $ 0.45       6.61     $ 548,780  
                                 
Exercisable, March 31, 2022     7,758,191     $ 0.38       7.88     $ 548,780  

 

Schedule of option activity
    Number
of
    Weighted
Average
Exercise
    Weighted
Average
Remaining
Contractual
    Aggregate
Intrinsic
 
Options   Shares     Price     Term     Value  
Balance Outstanding, December 31, 2021     11,753,422     $ 0.36       9.47     $ 196,825  
Granted    
-
     
-
     
-
     
-
 
Forfeited    
-
     
-
     
-
     
-
 
Exercised    
-
     
-
     
-
     
-
 
Expired    
-
     
-
     
-
     
-
 
Balance Outstanding, March 31, 2022     11,753,422     $ 0.36       9.23     $ 368,767  
                                 
Exercisable, March 31, 2022     7,878,665     $ 0.43       9.02     $ 94,007